India, July 29 -- Hyderabad-based Cohance Lifesciences Ltd. (formerly Suven Pharmaceuticals Limited), a leading integrated Contract Development and Manufacturing Organization (CDMO), has announced the appointment of Yann D'Herve as Chief Executive Officer (CEO) of the company's CDMO business.

The business operates as a fully integrated, innovation-led platform serving global pharmaceutical companies, including capabilities in small molecule APIs, Antibody Drug Conjugates (ADCs) and Nucleic Acid Chemistry.

Effective August 1, 2025, D'Herve's appointment brings a strong track record of senior-level leadership to Cohance. He has a rich and diverse background spanning multiple business functions and geographies. His experience includes lead...